The DOI matches its Crossref record; 233 of the 233 references it cites were found in a registry or an index.
Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy
Open accessAbstract
Diabetic retinopathy remains the major cause of blindness among working age adults. Although a number of metabolic abnormalities have been associated with its development, due to complex nature of this multi-factorial disease, a link between any specific abnormality and diabetic retinopathy remains largely speculative. Diabetes increases oxidative stress in the retina and its capillary cells, and overwhelming evidence suggests a bidirectional relationship between oxidative stress and other major metabolic abnormalities implicated in the development of diabetic retinopathy. Due to increased production of cytosolic reactive oxygen species, mitochondrial membranes are damaged and their membrane potentials are impaired, and complex III of the electron transport system is compromised. Suboptimal enzymatic and nonenzymatic antioxidant defense system further aids in the accumulation of free radicals. As the duration of the disease progresses, mitochondrial DNA (mtDNA) is damaged and the DNA repair system is compromised, and due to impaired transcription of mtDNA-encoded proteins, the integrity of the electron transport system is encumbered. Due to decreased mtDNA biogenesis and impaired transcription, superoxide accumulation is further increased, and the vicious cycle of free radicals continues to self-propagate. Diabetic milieu also alters enzymes responsible for DNA and histone modifications, and various genes important for mitochondrial homeostasis, including mitochondrial biosynthesis, damage and antioxidant defense, undergo epigenetic modifications. Although antioxidant administration in animal models has yielded encouraging results in preventing diabetic retinopathy, controlled longitudinal human studies remain to be conducted. Furthermore, the role of epigenetic in mitochondrial homeostasis suggests that regulation of such modifications also has potential to inhibit/retard the development of diabetic retinopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–233 of 233
Kowluru, R., Kern, T. S., & Engerman, R. L. (1994) · Current Eye Research · doi:10.3109/02713689409015092 · Cited by 73
Self-citationTreatment of vascular retinopathies with Pycnogenol®
Spadea, L., & Balestrazzi, E. (2001) · Phytotherapy Research · doi:10.1002/ptr.853 · Cited by 72
Syreeni, A., El‐Osta, A., Forsblom, C. M., Sandholm, N., Parkkonen, M., Tarnow, L., Parving, H., McKnight, A. J., Maxwell, A. P., Cooper, M. E., et al. (2011) · Diabetes · doi:10.2337/db11-0073 · Cited by 71
dos Santos, J. M., Mishra, M., & Kowluru, R. A. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.02.010 · Cited by 70
Self-citationMishra, M., & Kowluru, R. A. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15020 · Cited by 69
Self-citationThe role of epigenetics in age-related macular degeneration
Gemenetzi, M. K., & Lotery, A. J. (2014) · Eye · doi:10.1038/eye.2014.225 · Cited by 67
Oxidative-stress-induced epigenetic changes in chronic diabetic complications
Feng, B., Ruiz, M. A., & Chakrabarti, S. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2012-0251 · Cited by 65
Millen, A. E., Gruber, M., Klein, R., Klein, B. E. K., Palta, M., & Mares, J. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg116 · Cited by 64
Sarkar, S., Goldgar, S., Byler, S., Rosenthal, S., & Heerboth, S. A. (2013) · Epigenomics · doi:10.2217/epi.12.68 · Cited by 62
Oxidative Stress in Preretinopathic Diabetes Subjects and Antioxidants
Nebbioso, M., Federici, M., Rusciano, D., Evangelista, M., & Pescosolido, N. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0172 · Cited by 58
Fu, D., Yu, Y., Wu, M., Du, M., Chen, Y., Abdelsamie, S. A., Li, Y., Chen, J., Boulton, M. E., Ma, J.-X., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m045401 · Cited by 58
Aberrant DNA methylation patterns in diabetic nephropathy
Maghbooli, Z., Larijani, B. A., Emamgholipour, S., Amini, M., Keshtkar, A., & Pasalar, P. (2014) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-13-69 · Cited by 58
dos Santos, J. M., & Kowluru, R. A. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2384 · Cited by 57
Self-citationAldose Reductase Expression in Human Diabetic Retina and Retinal Pigment Epithelium
Vinores, S. A., Campochiaro, P. A., Williams, E. H., May, E. E., Green, W. R., & Sorenson, R. L. (1988) · Diabetes · doi:10.2337/diab.37.12.1658 · Cited by 56
MicroRNAs and Epigenetics in Adult Neurogenesis
Wakabayashi, T., Hidaka, R., Fujimaki, S., Asashima, M., & Kuwabara, T. (2014) · Advances in genetics · doi:10.1016/b978-0-12-800222-3.00002-4 · Cited by 54
Personalized Medicine and Type 2 Diabetes: Lesson from Epigenetics
Raciti, G. A., Nigro, C., Longo, M., Parrillo, L., Miele, C., Formisano, P., & Bèguinot, F. (2014) · Epigenomics · doi:10.2217/epi.14.10 · Cited by 53
Interrelationships between the Retinal Neuroglia and Vasculature in Diabetes
Kern, T. S. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.3.163 · Cited by 52
Targeted therapies in epithelial ovarian cancer: Molecular mechanisms of action
Itamochi, H. (2010) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v1.i7.209 · Cited by 51
Bonnefond, A., Saulnier, P., Stathopoulou, M. G., Grarup, N., Ndiaye, N. C., Roussel, R., Azimi–Nezhad, M., Dechaume, A., Lantieri, O., Herçberg, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055921 · Cited by 50
dos Santos, J. M., Tewari, S., Lin, J. Y., & Kowluru, R. A. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.07.066 · Cited by 50
Self-citationMitochondrial DNA: a blind spot in neuroepigenetics
Manev, H., Dzitoyeva, S., & Chen, H. (2012) · BioMolecular Concepts · doi:10.1515/bmc-2011-0058 · Cited by 50
Effect of Dicarbonyl Modification of Fibronectin on Retinal Capillary Pericytes
Liu, B.-F., Bhat, M. B., Padival, A. K., Smith, D. G., & Nagaraj, R. H. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0995 · Cited by 46
Calcium Dobesilate in the Treatment of Diabetic Retinopathy
Garay, R. P., Hannaert, P. A., & Chiavaroli, C. (2005) · Treatments in Endocrinology · doi:10.2165/00024677-200504040-00003 · Cited by 46
Epigenetic Modifications and Potential New Treatment Targets in Diabetic Retinopathy
Perrone, L., Matrone, C., & Singh, L. P. (2014) · Journal of Ophthalmology · doi:10.1155/2014/789120 · Cited by 44
Madsen‐Bouterse, S. A., Mohammad, G., & Kowluru, R. A. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4171 · Cited by 42
Self-citationReplication Analysis for Severe Diabetic Retinopathy
Grassi, M. A., Тихомиров, А. А., Ramalingam, S., Lee, K. E., Hosseini, S. M., Klein, B. E. K., Klein, R., Lussier, Y. A., Cox, N. J., & Nicolae, D. L. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8068 · Cited by 42
Kim, J., Hwang, J., Jeong, H., Song, H., Shin, J., Hur, G. M., Park, Y. W., Lee, S. H., & Kim, J. (2012) · Epigenetics · doi:10.4161/epi.7.2.18973 · Cited by 36
Miao, F., Chen, Z., Zhang, L., Wang, J., Gao, H., Wu, X., & Natarajan, R. D. (2013) · Physiological Genomics · doi:10.1152/physiolgenomics.00001.2013 · Cited by 36
Niu, P.-P., Cao, Y., Gong, T., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-170 · Cited by 32
Sugawara, R., Hikichi, T., Kitaya, N., Mori, F., Nagaoka, T., Yoshida, A., & Szabó, C. (2004) · Current Eye Research · doi:10.1080/02713680490513146 · Cited by 30
Epigenetics and type II diabetes mellitus: underlying mechanisms of prenatal predisposition
Sterns, J. D., Smith, C. B., Steele, J. R., Stevenson, K. L., & Gallicano, G. I. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00015 · Cited by 30
Kearney, F. M., Fagan, X. J., & Al‐Qureshi, S. (2013) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.12290 · Cited by 25
The role of Raf-1 kinase in diabetic retinopathy
Mohammad, G., & Kowluru, R. A. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.553604 · Cited by 17
Self-citation
Cited by
The progress in understanding and treatment of diabetic retinopathy
Stitt, A. W., Curtis, T. M., Chen, M., Medina, R. J., McKay, G. J., Jenkins, A., Gardiner, T. A., Lyons, T. J., Hammes, H.-P., Simó, R., et al. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.08.001 · Cited by 1,164
Wong, T. Y., Cheung, C. M. G., Larsen, M., Sharma, S., & Simó, R. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.12 · Cited by 1,094
Kang, Q., & Yang, C. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101799 · Cited by 1,066
Diabetic retinopathy: current understanding, mechanisms, and treatment strategies
Duh, E. J., Sun, J. K., & Stitt, A. W. (2017) · JCI Insight · doi:10.1172/jci.insight.93751 · Cited by 1,057
“The concept of epigenetic modifications associated with the metabolic memory phenomenon is an additional pathogenic process worthy of therapeutic attention (123).”
BackgroundMitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances
Xu, X., Pang, Y., & Fan, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02253-4 · Cited by 800
Metadata
- Authors
- Kowluru, R. A., Kowluru, A., Mishra, M., & Kumar, B.
- Venue
- Progress in Retinal and Eye Research
- Publisher
- Elsevier BV
- Published
- 2015-09
- Volume
- 48
- Pages
- 40-61
- ISSN
- 1350-9462 (ISSN-L)
- OpenAlex
- W220518476
- Cited by
- 333
- References
- 233
- FWCI
- 22.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.